Impact of Metastatic Location on Survival in Stage-IV Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy

被引：1
|
作者：
Naqash, A. R. [1 ]
Jonnalagadda, S. [1 ]
Macherla, S. [1 ]
Polsani, S. [1 ]
Muzaffar, M. [1 ]
Cherry, C. [1 ]
Karim, N. Abdel [2 ]
Walker, P. [1 ]
机构：
[1] East Carolina Univ, Greenville, NC 27858 USA
[2] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Non-Small Cell Lung Cancer; Immune Checkpoint Inhibition; metastatic sites;
D O I：
10.1016/j.jtho.2019.08.963
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-60
引用
收藏
页码：S464 / S464
页数：1
相关论文
共 50 条
  • [1] Trends in immunotherapy use and survival impact in stage IV non-small cell lung cancer.
    Otaibi, Zachary
    Kamran, Amir
    Wegner, Rodney E.
    Colonias, Athanasios
    Weksler, Benny
    Finley, Gene Grant
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [3] Three-year survival in stage IV non-small cell lung cancer (NSCLC): The importance of metastatic distribution
    Karp, Daniel D.
    Hanneken, Jan M.
    Taylor, Sarah H.
    Men, Taoyan
    Wu, Xifeng
    Pu, Xia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Clinicopathologic Characteristics And Predictors Of Survival In Stage Iv Non-Small Cell Lung Cancer (nsclc)
    Duma, N.
    Listo, M.
    Osorio, C.
    Zhang, S.
    Kang, M.
    Abu-Ihweij, K.
    Harper, H.
    Gutierrez, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [5] Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)
    Yumuk, P. F.
    Teomete, M.
    Dane, F.
    Cabuk, D.
    Basaran, G.
    Turhal, N. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Survival Impact of Patient Enrollment in Antineoplastic Drug Trials for Stage IV Non-Small Cell Lung Cancer (NSCLC)
    Goulart, B.
    Silgard, E.
    Stricker, K.
    Eaton, K.
    Martins, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S995 - S995
  • [7] Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer
    Fung, A.
    D'Silva, A.
    Li, H.
    Otsuka, S.
    Bebb, D. G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2077 - S2078
  • [8] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    [J]. INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [9] Clinical characteristics influencing survival in stage-IV non-small cell lung cancer treated with nivolumab: A single-institutional experience
    Naqash, Abdul Rafeh
    Stroud, Chipman R.
    Yang, Li V.
    Muzaffar, Mahvish
    Walker, Paul R.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [10] Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC)
    Gijtenbeek, Rolof G. P.
    Helfrich, Gea
    Venmans, Ben J. W.
    Ten Brinke, Anneke
    De Jong, Kim
    Van Geffen, Wouter H.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345